University of California San Diego is conducting new, Phase 2/3 national epilepsy clinical research trials, called Rise, to study BHV-7000, a novel investigational therapy, in focal epilepsy. University of California San Diego is conducting new, Phase 2/3 national epilepsy clinical research trials, called Rise, to study BHV-7000, a novel investigational therapy, in focal epilepsy. UC San Diego is one of more than 95 sites in the country participating in the Rise studies. Epilepsy is one of the most common neurological diseases globally, affecting approximately 1.5 million people in the US and 50 million worldwide.1,2 Approximately 40% of people with epilepsy are drug-resistant, unde
Hence then, the article about uc san diego recruiting people with focal epilepsy for national study evaluating new treatment candidate for epilepsy was published today ( ) and is available onTimes of San Diego ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( UC San Diego Recruiting People With Focal Epilepsy for National Study Evaluating New Treatment Candidate for Epilepsy )